Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC43H46ClN7O8S |
InChIKeyLGASPVUKBCDRLN-UHFFFAOYSA-N |
CAS Registry2922747-81-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 26 May 2023 |